Mapping the Binding of GluN2B-Selective N-Methyl-D-aspartate Receptor Negative Allosteric Modulators

被引:40
作者
Burger, Pieter B. [1 ]
Yuan, Hongjie [2 ]
Karakas, Erkan [3 ]
Geballe, Matthew [1 ]
Furukawa, Hiro [3 ]
Liotta, Dennis C. [1 ]
Snyder, James P. [1 ]
Traynelis, Stephen F. [2 ]
机构
[1] Emory Univ, Dept Chem, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Pharmacol, Atlanta, GA USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
基金
美国国家卫生研究院;
关键词
AMINO-TERMINAL DOMAIN; ANTI-ISCHEMIC AGENTS; NMDA RECEPTOR; NR2B SUBUNIT; ANTAGONIST PROPERTIES; PI INTERACTIONS; IFENPRODIL; PROTEIN; SUBTYPE; MECHANISMS;
D O I
10.1124/mol.112.078568
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have used recent structural advances in our understanding of the N-methyl-D-aspartate (NMDA) receptor amino terminal domain to explore the binding mode of multiple diaryl GluN2B-selective negative allosteric modulators at the interface between the GluN1 and GluN2B amino-terminal domains. We found that interaction of the A ring within the binding pocket seems largely invariant for a variety of structurally distinct ligands. In addition, a range of structurally diverse linkers between the two aryl rings can be accommodated by the binding site, providing a potential opportunity to tune interactions with the ligand binding pocket via changes in hydrogen bond donors, acceptors, as well as stereochemistry. The most diversity in atomic interactions between protein and ligand occur in the B ring, with functional groups that contain electron donors and acceptors providing additional atomic contacts within the pocket. A cluster of residues distant to the binding site also control ligand potency, the degree of inhibition, and show ligand-induced increases in motion during molecular dynamics simulations. Mutations at some of these residues seem to distinguish between structurally distinct ligands and raise the possibility that GluN2B-selective ligands can be divided into multiple classes. These results should help facilitate the development of well tolerated GluN2B subunit-selective antagonists.
引用
收藏
页码:344 / 359
页数:16
相关论文
共 50 条
  • [1] A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists
    Liu, Wenwu
    Jiang, Xiaowen
    Zu, Yuxin
    Yang, Yue
    Liu, Yaqian
    Sun, Xue
    Xu, Zihua
    Ding, Huaiwei
    Zhao, Qingchun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
  • [2] Phase 1 Clinical Results for NP10679, a pH-sensitive GluN2B-selective N-methyl-d-aspartate Receptor Inhibitor
    Zaczek, Robert
    Traynelis, Stephen F.
    Dingledine, Ray
    Koszalka, George W.
    Laskowitz, Daniel T.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (07): : 706 - 717
  • [3] Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the N-Methyl-d-aspartate Receptor
    D'Erasmo, Michael P.
    Akins, Nicholas S.
    Ma, Peipei
    Jing, Yao
    Swanger, Sharon A.
    Sharma, Savita K.
    Bartsch, Perry W.
    Menaldino, David S.
    Arcoria, Paul J.
    Bui, Thi-Thien
    Pons-Bennaceur, Alexandre
    Le, Phuong
    Allen, James P.
    Ullman, Elijah Z.
    Nocilla, Kelsey A.
    Zhang, Jing
    Perszyk, Riley E.
    Kim, Sukhan
    Acker, Timothy M.
    Taz, Azmain
    Burton, Samantha L.
    Coe, Kevin
    Fritzemeier, Russell G.
    Burnashev, Nail
    Yuan, Hongjie
    Liotta, Dennis C.
    Traynelis, Stephen F.
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (17): : 3059 - 3076
  • [4] Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit
    Buemi, Maria Rosa
    De Luca, Laura
    Ferro, Stefania
    Russo, Emilio
    De Sarro, Giovambattista
    Gitto, Rosaria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (07) : 1513 - 1519
  • [5] Mechanism for Noncompetitive Inhibition by Novel GluN2C/D N-Methyl-D-aspartate Receptor Subunit-Selective Modulators
    Acker, Timothy M.
    Yuan, Hongjie
    Hansen, Kasper B.
    Vance, Katie M.
    Ogden, Kevin K.
    Jensen, Henrik S.
    Burger, Pieter B.
    Mullasseril, Praseeda
    Snyder, James P.
    Liotta, Dennis C.
    Traynelis, Stephen F.
    MOLECULAR PHARMACOLOGY, 2011, 80 (05) : 782 - 795
  • [6] Phenol-Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B-selective N-methyl- d-aspartate receptor antagonists
    Markus, Alexander
    Schreiber, Julian A.
    Goerges, Gunnar
    Frehland, Bastian
    Seebohm, Guiscard
    Schepmann, Dirk
    Wuensch, Bernhard
    ARCHIV DER PHARMAZIE, 2022, 355 (09)
  • [7] Effect of Ifenprodil on GluN1/GluN2B N-Methyl-D-aspartate Receptor Gating
    Bhatt, Jay M.
    Prakash, Anand
    Suryavanshi, Pratyush S.
    Dravid, Shashank M.
    MOLECULAR PHARMACOLOGY, 2013, 83 (01) : 9 - 21
  • [8] 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators
    Chrovian, Christa C.
    Soyode-Johnson, Akinola
    Wall, Jessica L.
    Rech, Jason C.
    Schoellerman, Jeff
    Lord, Brian
    Coe, Kevin J.
    Carruthers, Nicholas I.
    Nguyen, Leslie
    Jiang, Xiaohui
    Koudriakova, Tatiana
    Balana, Bartosz
    Letavic, Michael A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (03): : 261 - 266
  • [9] Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid
    Irvine, Mark W.
    Fang, Guangyu
    Sapkota, Kiran
    Burnell, Erica S.
    Volianskis, Arturas
    Costa, Blaise M.
    Culley, Georgia
    Collingridge, Graham L.
    Monaghan, Daniel T.
    Jane, David E.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 471 - 498
  • [10] A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists
    Stroebel, David
    Buhl, Derek L.
    Knafels, John D.
    Chanda, Pranab K.
    Green, Michael
    Sciabola, Simone
    Mony, Laetitia
    Paoletti, Pierre
    Pandit, Jayvardhan
    MOLECULAR PHARMACOLOGY, 2016, 89 (05) : 541 - 551